(19)
(11) EP 3 220 967 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.11.2019 Bulletin 2019/47

(45) Mention of the grant of the patent:
19.06.2019 Bulletin 2019/25

(21) Application number: 15794143.6

(22) Date of filing: 10.11.2015
(51) International Patent Classification (IPC): 
A61L 27/12(2006.01)
A61Q 19/08(2006.01)
A61K 8/67(2006.01)
 A61K 8/24(2006.01)
A61K 9/14(2006.01)
(86) International application number:
PCT/EP2015/076222
(87) International publication number:
WO 2016/078971 (26.05.2016 Gazette 2016/21)

(54)

MORPHOGENETICALLY ACTIVE AMORPHOUS CALCIUM POLYPHOSPHATE NANOPARTICLES FOR THERAPEUTIC APPLICATIONS

MORPHOGENETISCH AKTIVE AMORPHE CALCIUMPOLYPHOSPHATNANOPARTIKEL FÜR THERAPEUTISCHE ANWENDUNGEN

NANOPARTICULES AMORPHES MORPHOGÉNÉTIQUEMENT ACTIVES DE POLYPHOSPHATE DE CALCIUM DESTINÉES À DES APPLICATIONS THÉRAPEUTIQUES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 17.11.2014 GB 201420363
09.02.2015 GB 201502116

(43) Date of publication of application:
27.09.2017 Bulletin 2017/39

(73) Proprietor: NanotecMARIN GmbH
55128 Mainz (DE)

(72) Inventor:
  • MÜLLER, Werner Ernst Ludwig Georg
    55129 Mainz (DE)

(74) Representative: Krauss, Jan 
Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22
80336 München
80336 München (DE)


(56) References cited: : 
WO-A2-2008/005509
 WO-A2-2008/006204
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).